These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

74 related articles for article (PubMed ID: 9381027)

  • 21. Long-term tacrine treatment in three mild Alzheimer patients: effects on nicotinic receptors, cerebral blood flow, glucose metabolism, EEG, and cognitive abilities.
    Nordberg A; Amberla K; Shigeta M; Lundqvist H; Viitanen M; Hellström-Lindahl E; Johansson M; Andersson J; Hartvig P; Lilja A; Långström B; Winblad B
    Alzheimer Dis Assoc Disord; 1998 Sep; 12(3):228-37. PubMed ID: 9772028
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Characteristics of adult day care participants who enter a nursing home.
    Cohen-Mansfield J; Wirtz PW
    Psychol Aging; 2007 Jun; 22(2):354-60. PubMed ID: 17563190
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Quality of life and cholinesterase inhibitors: a qualitative study of patients with Alzheimer's disease and their carers.
    Smith B; Chur-Hansen A; Neale A; Symon J
    Australas Psychiatry; 2008 Dec; 16(6):433-7. PubMed ID: 18777227
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Efficacy and safety of donepezil over 3 years: an open-label, multicentre study in patients with Alzheimer's disease.
    Burns A; Gauthier S; Perdomo C
    Int J Geriatr Psychiatry; 2007 Aug; 22(8):806-12. PubMed ID: 17199235
    [TBL] [Abstract][Full Text] [Related]  

  • 25. One year on tacrine (THA): clinical and biochemical effects in patients with dementia of the Alzheimer type.
    Ahlin A; Junthé T; Hassan M; Nybäck H
    Int Psychogeriatr; 1995; 7(1):75-83. PubMed ID: 7579023
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Donepezil treatment of patients with severe Alzheimer's disease in a Japanese population: results from a 24-week, double-blind, placebo-controlled, randomized trial.
    Homma A; Imai Y; Tago H; Asada T; Shigeta M; Iwamoto T; Takita M; Arimoto I; Koma H; Ohbayashi T
    Dement Geriatr Cogn Disord; 2008; 25(5):399-407. PubMed ID: 18391486
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Pharmacological treatment in severe dementia].
    Jouanny P; Belliard S; Bentué-Ferrer D; Michel O; Allain H
    Psychol Neuropsychiatr Vieil; 2005 Mar; 3 Suppl 1():S51-5. PubMed ID: 15899605
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Medical treatment of Alzheimer's disease: past, present, and future.
    Ott BR
    Med Health R I; 2002 Jul; 85(7):210-2. PubMed ID: 12182092
    [No Abstract]   [Full Text] [Related]  

  • 29. Caregiver burden: three voices-three realities.
    Wright JF; Doherty ME; Dumas LG
    Nurs Clin North Am; 2009 Jun; 44(2):209-21. PubMed ID: 19463677
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Caregiver preference for rivastigmine patches versus capsules for the treatment of Alzheimer disease.
    Blesa R; Ballard C; Orgogozo JM; Lane R; Thomas SK
    Neurology; 2007 Jul; 69(4 Suppl 1):S23-8. PubMed ID: 17646620
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Effect of tacrine on behavioral symptoms in Alzheimer's disease: an open-label study.
    Kaufer DI; Cummings JL; Christine D
    J Geriatr Psychiatry Neurol; 1996 Jan; 9(1):1-6. PubMed ID: 8679057
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Impact of music therapy on anxiety and depression for patients with Alzheimer's disease and on the burden felt by the main caregiver (feasibility study)].
    Guetin S; Portet F; Picot MC; Defez C; Pose C; Blayac JP; Touchon J
    Encephale; 2009 Feb; 35(1):57-65. PubMed ID: 19250995
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Assessing quality of life in Taiwanese patients with Alzheimer's disease.
    Fuh JL; Wang SJ
    Int J Geriatr Psychiatry; 2006 Feb; 21(2):103-7. PubMed ID: 16416471
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Alzheimer's disease.
    Kennedy-Malone LM; Fletcher K
    Lippincotts Prim Care Pract; 1999; 3(2):163-8. PubMed ID: 10426059
    [No Abstract]   [Full Text] [Related]  

  • 35. Evaluating the outcome of interventions on quality of life in dementia: selection of the appropriate scale.
    Schölzel-Dorenbos CJ; Ettema TP; Bos J; Boelens-van der Knoop E; Gerritsen DL; Hoogeveen F; de Lange J; Meihuizen L; Dröes RM
    Int J Geriatr Psychiatry; 2007 Jun; 22(6):511-9. PubMed ID: 17133655
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [What do nurses expect from therapy of Alzheimer disease].
    Riesner C
    Krankenpfl J; 2005; 43(7-10):209. PubMed ID: 16515280
    [No Abstract]   [Full Text] [Related]  

  • 37. [Pharma-clinics. Drug of the month. Tacrine (Cognex)].
    Scheen AJ
    Rev Med Liege; 1996 May; 51(5):379-81. PubMed ID: 8992561
    [No Abstract]   [Full Text] [Related]  

  • 38. Behavior as an efficacy outcome.
    Cummings JL
    Alzheimer Dis Assoc Disord; 1997; 11 Suppl 4():v-vi. PubMed ID: 9339265
    [No Abstract]   [Full Text] [Related]  

  • 39. Tacrine in Alzheimer's disease.
    Lancet; 1991 Jun; 337(8755):1475-6. PubMed ID: 1675337
    [No Abstract]   [Full Text] [Related]  

  • 40. Tacrine and nursing home placement.
    Thal LJ; Thomas RG; Sano M
    Neurology; 1997 Sep; 49(3):897-9. PubMed ID: 9305370
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.